Crossed IPO listing price with volumes and retraced
Updated
Windlas Biotech - CDMO. It manufactures medicines for big pharma companies.
Stock price moved above IPO listing price with volumes.
Price retraced and trying to move higher again.
My analysis it is doing similar to Mrs. Bector Foods price movement after it crossed IPO listing price.
If Pharma companies are doing Capex and the sector rotation happens then it should take Windlas higher.
Not a trading but thinking of it is a positional view. I will start investing in very less quantities hoping to make a decent return.
Check fundamentals before investing.
Stock price moved above IPO listing price with volumes.
Price retraced and trying to move higher again.
My analysis it is doing similar to Mrs. Bector Foods price movement after it crossed IPO listing price.
If Pharma companies are doing Capex and the sector rotation happens then it should take Windlas higher.
Not a trading but thinking of it is a positional view. I will start investing in very less quantities hoping to make a decent return.
Check fundamentals before investing.
Note
I have a view of one or two years at max. Not for long term holding. There are lot of big CDMO companies in the market Syngene etc. It might turn negative but I am investing only the amount that I am okay or comfortable to loose.
Note
I am still holding Windlas. Added 13 shares till now.Windlas competitor Akum Drugs ( CDMO for Cipla, SUN, etc ) filed RHP with SEBI. Usually if an IPO is coming then the prices of the competitors also moves up. This is just an observation not a thumb rule. if market crashes IPOs will not come or IPOs will not perform/subscribe.
Keep a track on this. Not trading or investment call.
Trade closed manually
I sold Windlas at 700/-. Invested in Akum Drugs 70@725/-
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.